Commercial Managed Care Market Offers Significant Regional Opportunity For Pharma, Exchanges And Medicaid Expansion Complete 2014 Growth Picture

NASHVILLE, Tenn., July 11, 2013 /PRNewswire/ -- HealthLeaders-InterStudy, the leading provider of managed care market intelligence, mines its proprietary data for implications, opportunities, challenges and trends. As pharmaceutical companies move through annual planning in the midst of Healthcare Reform, incorporating the latest set of insights into strategic assumptions becomes essential.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36797LOGO)

"Forecasting the effects of Medicaid expansion and Exchanges in 2014 is nearly impossible," says Rebecca Waller, Principal Analyst at HealthLeaders-InterStudy.  "Yet that's where many executives are focusing their attention, almost exclusively.  It's easy to get wrapped up in the excitement of Healthcare Reform, but it's still just a small portion of the larger health insurance market."

Plans for strategic growth must incorporate the latest changes in the dynamic U.S. healthcare marketplace. In a new webinar open to pharmaceutical executives, HealthLeaders-InterStudy takes a look at the things that matter: State Exchanges and the players involved in them, mergers, market shares, Medicaid expansion and commercial growth on a national and regional scale.

"Some insurers are looking to expand their Medicaid business by entering the Exchanges, but others are being cautious.  Instead, they are changing their market segment focus and geographic concentration in ways that will affect many of the 212 million lives already covered," explains Jodi Tonkin, Principal Analyst at HealthLeaders-InterStudy. "Pharma companies looking for growth in 2014 will need to consider the wider picture—including trends outside of Healthcare Reform, like insurers gaining more traction with restrictive product offerings on the medical and pharmacy side of the business."

Upcoming Open Webinar!
Planning For Growth in 2014: Don't Miss the Forest by Staring at a Tree
August 8, 2013  |  12pm Eastern  |  9am Pacific 
HealthLeaders-InterStudy analysts Rebecca Waller and Jodi Tonkin walk through insights from new proprietary data in this upcoming webinar, which is open to pharmaceutical executives and especially created to help those moving through the Annual Planning process. For more information and to register, please click here.

About HealthLeaders-InterStudy
HealthLeaders-InterStudy, a Decision Resources Group company, is the authoritative source for managed care data, analysis, and news. HealthLeaders-InterStudy is part of the Market Access Business Unit at Decision Resources Group which also includes Abacus International, Fingertip Formulary, Pinsonault, and PharmaStrat. Find out more at www.hl-isy.com.

About Decision Resources Group
Decision Resources Group is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources Group at www.DecisionResourcesGroup.com.

All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.

SOURCE HealthLeaders-InterStudy